APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urokinase

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Selected research

Industry Growth & Trends

Global Urokinase Industry Growth and Trends Forecast to 2032

21 December 202597 pages

Choose your research edition.

Industry ResearchUrokinase Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Urokinase Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Urokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urokinase Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Urokinase Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Global Urokinase (CAS 9039-53-6) main manufactuers include Syner-Med, LIVZON, Wanhua Biochem and Techpool, totally accounting for about 50% of the market. China is the largest market of Urokinase (CAS 9039-53-6), holding a share about 56%. As for the types of products, it can be divided into urokinase powder and urokinase polution. The most common type is urokinase powder, with a share about 92%. As for the applications of products, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share about 78%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Urokinase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Urokinase market size, estimates, and forecasts are presented in terms of sales volume (BIU) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urokinase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urokinase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Urokinase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Urokinase Market by Company

Syner-Med

Wanhua Biochem

Jiangxi Haoran Bio-Pharma

Jiangsu Aidea Pharmaceutical

Techpool

Microbic Biosystems

LIVZON

Urokinase Segment by Type

Urokinase Powder

Urokinase Solution

Urokinase Segment by Application

Hospital

Clinic

Others

Urokinase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urokinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Urokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Urokinase Powder Table 2. Major Company of Urokinase Solution Table 3. Global Urokinase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Urokinase Sales by Type (2021-2026) & (BIU) Table 5. Global Urokinase Sales Market Share in Volume by Type (2021-2026) Table 6. Global Urokinase Sales by Type (2021-2026) & (US$ Million) Table 7. Global Urokinase Sales Market Share in Value by Type (2021-2026) Table 8. Global Urokinase Price by Type (2021-2026) & (US$/MIU) Table 9. Global Urokinase Sales by Type (2027-2032) & (BIU) Table 10. Global Urokinase Sales Market Share in Volume by Type (2027-2032) Table 11. Global Urokinase Sales by Type (2027-2032) & (US$ Million) Table 12. Global Urokinase Sales Market Share in Value by Type (2027-2032) Table 13. Global Urokinase Price by Type (2027-2032) & (US$/MIU) Table 14. North America Urokinase Sales by Type (2021-2026) & (BIU) Table 15. North America Urokinase Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Urokinase Sales by Type (2021-2026) & (BIU) Table 17. Europe Urokinase Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Urokinase Sales by Type (2021-2026) & (BIU) Table 19. Asia-Pacific Urokinase Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Urokinase Sales by Type (2021-2026) & (BIU) Table 21. Latin America Urokinase Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Urokinase Sales by Type (2021-2026) & (BIU) Table 23. Middle East and Africa Urokinase Sales by Type (2021-2026) & (US$ Million) Table 24. Urokinase Industry Trends Table 25. Urokinase Industry Drivers Table 26. Urokinase Industry Opportunities and Challenges Table 27. Urokinase Industry Restraints Table 28. Global Urokinase Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Urokinase Revenue Market Share by Company (2021-2026) Table 30. Global Urokinase Sales by Company (2021-2026) & (BIU) Table 31. Global Urokinase Sales Share by Company (2021-2026) Table 32. Global Urokinase Market Price by Company (2021-2026) & (US$/MIU) Table 33. Global Urokinase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Urokinase Major Company Production Sites and Headquarters Table 35. Global Urokinase Company, Product Type & Application Table 36. Global Urokinase Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Urokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Urokinase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Urokinase Sales by Region (2021-2026) & (BIU) Table 41. Global Urokinase Sales Market Share in Volume by Region (2021-2026) Table 42. Global Urokinase Sales by Region (2021-2026) & (US$ Million) Table 43. Global Urokinase Sales Market Share in Value by Region (2021-2026) Table 44. Global Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 45. Global Urokinase Sales by Region (2027-2032) & (BIU) Table 46. Global Urokinase Sales Market Share in Volume by Region (2027-2032) Table 47. Global Urokinase Sales by Region (2027-2032) & (US$ Million) Table 48. Global Urokinase Sales Market Share in Value by Region (2027-2032) Table 49. Global Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2027-2032) Table 50. Global Urokinase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Urokinase Sales by Application (2021-2026) & (BIU) Table 52. Global Urokinase Sales Market Share in Volume by Application (2021-2026) Table 53. Global Urokinase Sales by Application (2021-2026) & (US$ Million) Table 54. Global Urokinase Sales Market Share in Value by Application (2021-2026) Table 55. Global Urokinase Price by Application (2021-2026) & (US$/MIU) Table 56. Global Urokinase Sales by Application (2027-2032) & (BIU) Table 57. Global Urokinase Sales Market Share in Volume by Application (2027-2032) Table 58. Global Urokinase Sales by Application (2027-2032) & (US$ Million) Table 59. Global Urokinase Sales Market Share in Value by Application (2027-2032) Table 60. Global Urokinase Price by Application (2027-2032) & (US$/MIU) Table 61. North America Urokinase Sales by Application (2021-2026) & (BIU) Table 62. North America Urokinase Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Urokinase Sales by Application (2021-2026) & (BIU) Table 64. Europe Urokinase Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Urokinase Sales by Application (2021-2026) & (BIU) Table 66. Asia-Pacific Urokinase Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Urokinase Sales by Application (2021-2026) & (BIU) Table 68. Latin America Urokinase Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Urokinase Sales by Application (2021-2026) & (BIU) Table 70. Middle East and Africa Urokinase Sales by Application (2021-2026) & (US$ Million) Table 71. Syner-Med Company Information Table 72. Syner-Med Business Overview Table 73. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 74. Syner-Med Urokinase Product Portfolio Table 75. Syner-Med Recent Development Table 76. Wanhua Biochem Company Information Table 77. Wanhua Biochem Business Overview Table 78. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 79. Wanhua Biochem Urokinase Product Portfolio Table 80. Wanhua Biochem Recent Development Table 81. Jiangxi Haoran Bio-Pharma Company Information Table 82. Jiangxi Haoran Bio-Pharma Business Overview Table 83. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 84. Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio Table 85. Jiangxi Haoran Bio-Pharma Recent Development Table 86. Jiangsu Aidea Pharmaceutical Company Information Table 87. Jiangsu Aidea Pharmaceutical Business Overview Table 88. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 89. Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio Table 90. Jiangsu Aidea Pharmaceutical Recent Development Table 91. Techpool Company Information Table 92. Techpool Business Overview Table 93. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 94. Techpool Urokinase Product Portfolio Table 95. Techpool Recent Development Table 96. Microbic Biosystems Company Information Table 97. Microbic Biosystems Business Overview Table 98. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 99. Microbic Biosystems Urokinase Product Portfolio Table 100. Microbic Biosystems Recent Development Table 101. LIVZON Company Information Table 102. LIVZON Business Overview Table 103. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 104. LIVZON Urokinase Product Portfolio Table 105. LIVZON Recent Development Table 106. North America Urokinase Market Size Growth Rate (CAGR) by Country (BIU): 2021 VS 2025 VS 2032 Table 107. North America Urokinase Sales by Country (2021-2026) & (BIU) Table 108. North America Urokinase Sales Market Share by Country (2021-2026) Table 109. North America Urokinase Sales Forecast by Country (2027-2032) & (BIU) Table 110. North America Urokinase Sales Market Share Forecast by Country (2027-2032) Table 111. North America Urokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Urokinase Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Urokinase Market Share by Country (2021-2026) Table 114. North America Urokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Urokinase Market Share Forecast by Country (2027-2032) Table 116. Europe Urokinase Market Size Growth Rate (CAGR) by Country (BIU): 2021 VS 2025 VS 2032 Table 117. Europe Urokinase Sales by Country (2021-2026) & (BIU) Table 118. Europe Urokinase Sales Market Share by Country (2021-2026) Table 119. Europe Urokinase Sales Forecast by Country (2027-2032) & (BIU) Table 120. Europe Urokinase Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Urokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Urokinase Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Urokinase Market Share by Country (2021-2026) Table 124. Europe Urokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Urokinase Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Urokinase Market Size Growth Rate (CAGR) by Country (BIU): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Urokinase Sales by Country (2021-2026) & (BIU) Table 128. Asia-Pacific Urokinase Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Urokinase Sales Forecast by Country (2027-2032) & (BIU) Table 130. Asia-Pacific Urokinase Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Urokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Urokinase Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Urokinase Market Share by Country (2021-2026) Table 134. Asia-Pacific Urokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Urokinase Market Share Forecast by Country (2027-2032) Table 136. Latin America Urokinase Market Size Growth Rate (CAGR) by Country (BIU): 2021 VS 2025 VS 2032 Table 137. Latin America Urokinase Sales by Country (2021-2026) & (BIU) Table 138. Latin America Urokinase Sales Market Share by Country (2021-2026) Table 139. Latin America Urokinase Sales Forecast by Country (2027-2032) & (BIU) Table 140. Latin America Urokinase Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Urokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Urokinase Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Urokinase Market Share by Country (2021-2026) Table 144. Latin America Urokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Urokinase Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Urokinase Market Size Growth Rate (CAGR) by Country (BIU): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Urokinase Sales by Country (2021-2026) & (BIU) Table 148. Middle East and Africa Urokinase Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Urokinase Sales Forecast by Country (2027-2032) & (BIU) Table 150. Middle East and Africa Urokinase Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Urokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Urokinase Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Urokinase Market Share by Country (2021-2026) Table 154. Middle East and Africa Urokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Urokinase Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Urokinase Distributors List Table 159. Urokinase Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Urokinase Image Figure 2. Global Urokinase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urokinase Market Size (2021-2032) & (US$ Million) Figure 4. Global Urokinase Sales (2021-2032) & (BIU) Figure 5. Urokinase Powder Image Figure 6. Global Urokinase Powder Sales YoY Growth (2021-2032) & (BIU) Figure 7. Urokinase Solution Image Figure 8. Global Urokinase Solution Sales YoY Growth (2021-2032) & (BIU) Figure 9. Global Urokinase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Urokinase Market Share by Type 2025 VS 2032 Figure 11. North America Urokinase Sales Market Share in Volume by Type in 2025 Figure 12. North America Urokinase Sales Market Share in Value by Type in 2025 Figure 13. Europe Urokinase Sales Market Share in Volume by Type in 2025 Figure 14. Europe Urokinase Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Urokinase Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Urokinase Sales Market Share in Value by Type in 2025 Figure 17. Latin America Urokinase Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Urokinase Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Urokinase Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Urokinase Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Urokinase Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (BIU) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (BIU) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (BIU) Figure 29. Global Urokinase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Urokinase Market Share by Application 2025 VS 2032 Figure 31. North America Urokinase Sales Market Share in Volume by Application in 2025 Figure 32. North America Urokinase Sales Market Share in Value by Application in 2025 Figure 33. Europe Urokinase Sales Market Share in Volume by Application in 2025 Figure 34. Europe Urokinase Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Urokinase Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Urokinase Sales Market Share in Value by Application in 2025 Figure 37. Latin America Urokinase Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Urokinase Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Urokinase Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Urokinase Sales Market Share in Value by Application in 2025 Figure 41. North America Urokinase Sales by Country: 2021 VS 2025 VS 2032 (BIU) Figure 42. North America Urokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Urokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Urokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Urokinase Sales by Country: 2021 VS 2025 VS 2032 (BIU) Figure 46. Europe Urokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Urokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Urokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Urokinase Sales by Country: 2021 VS 2025 VS 2032 (BIU) Figure 50. Asia-Pacific Urokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Urokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Urokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Urokinase Sales by Country: 2021 VS 2025 VS 2032 (BIU) Figure 54. Latin America Urokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Urokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Urokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Urokinase Sales by Country: 2021 VS 2025 VS 2032 (BIU) Figure 58. Middle East and Africa Urokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Urokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Urokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Urokinase Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Urokinase Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Urokinase Powder
  • Urokinase Solution
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Syner-Med
  • Wanhua Biochem
  • Jiangxi Haoran Bio-Pharma
  • Jiangsu Aidea Pharmaceutical
  • Techpool
  • Microbic Biosystems
  • LIVZON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urokinase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Urokinase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Urokinase Market by Type
  6. 1.3.1 Urokinase Powder
  7. 1.3.2 Urokinase Solution
  8. 1.4 Global Urokinase Market Size by Type
  9. 1.4.1 Global Urokinase Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Urokinase Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Urokinase Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Urokinase Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Urokinase Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Urokinase Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Urokinase Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Urokinase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Urokinase Industry Trends
  2. 2.2 Urokinase Industry Drivers
  3. 2.3 Urokinase Industry Opportunities and Challenges
  4. 2.4 Urokinase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Urokinase Revenue (2021-2026)
  2. 3.2 Global Top Players by Urokinase Sales (2021-2026)
  3. 3.3 Global Top Players by Urokinase Price (2021-2026)
  4. 3.4 Global Urokinase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Urokinase Major Company Production Sites & Headquarters
  6. 3.6 Global Urokinase Company, Product Type & Application
  7. 3.7 Global Urokinase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Urokinase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Urokinase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Urokinase Tier 1, Tier 2, and Tier 3
4 Urokinase Regional Status and Outlook
  1. 4.1 Global Urokinase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Urokinase Historic Market Size by Region
  3. 4.2.1 Global Urokinase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Urokinase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Urokinase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Urokinase Forecasted Market Size by Region
  7. 4.3.1 Global Urokinase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Urokinase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Urokinase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Urokinase by Application
  1. 5.1 Urokinase Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Urokinase Market Size by Application
  6. 5.2.1 Global Urokinase Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Urokinase Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Urokinase Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Urokinase Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Urokinase Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Urokinase Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Urokinase Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Urokinase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Syner-Med
  2. 6.1.1 Syner-Med Company Information
  3. 6.1.2 Syner-Med Business Overview
  4. 6.1.3 Syner-Med Urokinase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Syner-Med Urokinase Product Portfolio
  6. 6.1.5 Syner-Med Recent Developments
  7. 6.2 Wanhua Biochem
  8. 6.2.1 Wanhua Biochem Company Information
  9. 6.2.2 Wanhua Biochem Business Overview
  10. 6.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Wanhua Biochem Urokinase Product Portfolio
  12. 6.2.5 Wanhua Biochem Recent Developments
  13. 6.3 Jiangxi Haoran Bio-Pharma
  14. 6.3.1 Jiangxi Haoran Bio-Pharma Company Information
  15. 6.3.2 Jiangxi Haoran Bio-Pharma Business Overview
  16. 6.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio
  18. 6.3.5 Jiangxi Haoran Bio-Pharma Recent Developments
  19. 6.4 Jiangsu Aidea Pharmaceutical
  20. 6.4.1 Jiangsu Aidea Pharmaceutical Company Information
  21. 6.4.2 Jiangsu Aidea Pharmaceutical Business Overview
  22. 6.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio
  24. 6.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
  25. 6.5 Techpool
  26. 6.5.1 Techpool Company Information
  27. 6.5.2 Techpool Business Overview
  28. 6.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Techpool Urokinase Product Portfolio
  30. 6.5.5 Techpool Recent Developments
  31. 6.6 Microbic Biosystems
  32. 6.6.1 Microbic Biosystems Company Information
  33. 6.6.2 Microbic Biosystems Business Overview
  34. 6.6.3 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Microbic Biosystems Urokinase Product Portfolio
  36. 6.6.5 Microbic Biosystems Recent Developments
  37. 6.7 LIVZON
  38. 6.7.1 LIVZON Company Information
  39. 6.7.2 LIVZON Business Overview
  40. 6.7.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 LIVZON Urokinase Product Portfolio
  42. 6.7.5 LIVZON Recent Developments
7 North America by Country
  1. 7.1 North America Urokinase Sales by Country
  2. 7.1.1 North America Urokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Urokinase Sales by Country (2021-2026)
  4. 7.1.3 North America Urokinase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Urokinase Market Size by Country
  6. 7.2.1 North America Urokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Urokinase Market Size by Country (2021-2026)
  8. 7.2.3 North America Urokinase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Urokinase Sales by Country
  2. 8.1.1 Europe Urokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Urokinase Sales by Country (2021-2026)
  4. 8.1.3 Europe Urokinase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Urokinase Market Size by Country
  6. 8.2.1 Europe Urokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Urokinase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Urokinase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Urokinase Sales by Country
  2. 9.1.1 Asia-Pacific Urokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Urokinase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Urokinase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Urokinase Market Size by Country
  6. 9.2.1 Asia-Pacific Urokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Urokinase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Urokinase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Urokinase Sales by Country
  2. 10.1.1 South America Urokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Urokinase Sales by Country (2021-2026)
  4. 10.1.3 South America Urokinase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Urokinase Market Size by Country
  6. 10.2.1 South America Urokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Urokinase Market Size by Country (2021-2026)
  8. 10.2.3 South America Urokinase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Urokinase Sales by Country
  2. 11.1.1 Middle East and Africa Urokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Urokinase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Urokinase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Urokinase Market Size by Country
  6. 11.2.1 Middle East and Africa Urokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Urokinase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Urokinase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Urokinase Value Chain Analysis
  2. 12.1.1 Urokinase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Urokinase Production Mode & Process
  7. 12.2 Urokinase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Urokinase Distributors
  10. 12.2.3 Urokinase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst